中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 11
Nov.  2016
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2016  >  32(11): 2126-2129

Influence of Forkhead box Q1 expression on therapeutic effect of transarterial chemoembolization after hepatocellular carcinoma surgery

DOI: 10.3969/j.issn.1001-5256.2016.11.024
Research funding:

 

  • Published Date: 2016-11-20
    Abstract
  • Objective To investigate the expression of Forkhead box Q1( FOXQ1) in the tissue of hepatocellular carcinoma( HCC),its influence on the prognosis of surgical resection combined with transarterial chemoembolization( TACE),and the value of FOXQ1 in evaluating the treatment outcome of HCC. Methods A total of 120 HCC patients who were admitted to The Affiliated Tumor Hospital of Nantong University from January 2004 to December 2007 were enrolled. Immunohistochemistry was used to measure the expression of FOXQ1 in HCC tissue,which was compared with patients' clinical features. The chi- square test was used for comparison of categorical data between groups,the Kaplan- Meier curve and log- rank test were used to analyze patients' disease- free survival( DFS) rates after surgery,and the Cox proportional hazards regression model was used for univariate and multivariate regression analyses. Results The results of immunohistochemistry showed that FOXQ1 had a dark- brown color in HCC tissue and was mainly expressed in tumor cytoplasm and nucleus. The univariate regression analysis showed that patients' DFS was affected by TNM stage( HR = 0. 347,95% CI: 0. 210- 0. 573,P < 0. 001),the number of tumors in the liver( HR = 0. 294,95% CI: 0. 176- 0. 490,P < 0. 001),HBV infection( HR = 0. 395,95% CI: 0. 222-0. 704,P = 0. 002),alpha- fetoprotein expression( HR = 0. 348,95% CI: 0. 207- 0. 586,P < 0. 001),presence or absence of liver cirrhosis( HR = 0. 414,95% CI: 0. 244- 0. 702,P = 0. 001),and high FOXQ1 expression level( HR = 1. 968,95% CI: 1. 171- 3. 308,P = 0. 011). Multivariate regression analysis showed that the patents' DFS was associated with TNM stage( HR = 0. 466,95% CI: 0. 248-0. 874,P = 0. 017),the number of tumors in the liver( HR = 0. 427,95% CI: 0. 216- 0. 844,P = 0. 014),and high FOXQ1 expression level( HR = 2. 896,95% CI: 1. 628- 5. 152,P < 0. 001). The patients with a high FOXQ1 expression level had a shorter DFS than those with a low FOXQ1 expression level( 18 months vs 26 months,χ2= 5. 006,P = 0. 025). Conclusion FOXQ1 can be used as a biomarker to evaluate the prognosis of HCC patients and the treatment outcome of HCC.

     

    • FullText(HTML)
    • References(14)
  • [1]WANG W,HE S,JI J,et al.The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma[J].Pathol Res Pract,2013,209(6):353-358.
    [2]KANEDA H,ARAO T,TANAKA K,et al.FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth[J].Cancer Res,2010,70(5):2053-2063.
    [3]ZHANG H,MENG F,LIU G,et al.Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis[J].Cancer Res,2011,71(4):1292-1301.
    [4]XIA L,HUANG W,TIAN D,et al.Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV 1 expression[J].Hepatology,2014,59(3):958-973.
    [5]FENG J,ZHANG X,ZHU H,et al.Fox Q1 overexpression influences poor prognosis in non-small cell lung cancer,associates with the phenomenon of EMT[J].PLoS One,2012,7(6):e39937.
    [6]PENG X,LUO Z,KANG Q,et al.FOXQ1 mediates the crosstalk between TGF-βand Wnt signaling pathways in the progression of colorectal cancer[J].Cancer Biol Ther,2015,16(7):1099-1109.
    [7]FENG J,XU L,NI S,et al.Involvement of Fox Q1 in NSCLC through regulating EMT and increasing chemosensitivity[J].Oncotarget,2014,5(20):9689-9702.
    [8]YAMAKADO K,HIROTA S.Sub-classification of intermediate-stage(Barcelona Clinic Liver Cancer stage-B)hepatocellular carcinomas[J].World J Gastroenterol,2015,21(37):10604-10608.
    [9]ZHOU YL,SHAO BF,SHI DH,et al.Association between PET-CT imaging and tumor pathological classification in hepatocellular carcinoma[J].J Nantong Univ:Med Sci,2012,32(5):391-393.(in Chinese)周益龙,邵冰峰,施冬辉,等.肝细胞肝癌PET-CT显像与肿瘤病理分级的相关性研究[J].南通大学学报:医学版,2012,32(5):391-393.
    [10]ZHOU YL SHAO BF,XU AB,et al.Value of indocyanine green retention rate at 15 minutes in surgical treatment of resectable liver cancer after multiple transarterial chemoembolization treatments[J].J Nantong Univ:Med Sci,2012,35(4):295-297.(in Chinese)周益龙,邵冰峰,徐爱兵,等.ICGR15在多次肝动脉栓塞化疗后的可切除性肝癌外科治疗中的意义[J].南通大学学报:医学版,2012,35(4):295-297.
    [11]CHENG HY.Interventional treatment for hepatocellular carcinoma:a review of current status and perspectives[J].J Clin Hepatol,2016,32(1):3-8.(in Chinese)程红岩.肝癌介入治疗的现状与展望[J].临床肝胆病杂志,2016,32(1):3-8.
    [12]MA SJ,ZOU SJ,LUO XL,et al.Prognostic factors for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma[J].J Clin Hepatol,2016,32(1):80-83.(in Chinese)马士杰,邹绍静,罗小玲,等.经肝动脉化疗栓塞术治疗肝细胞癌的预后影响因素分析[J].临床肝胆病杂志,2016,32(1):80-83.
    [13]FENG M,E CY,LI H,et al.Expression of miR-196a in liver cancer cells and its promotion effect on proliferation[J].J Jilin Univ:Med Edit,2015,41(1):120-124.(in Chinese)冯默,鄂长勇,李航,等.miR-196a在肝癌细胞中的表达及其促增殖作用[J].吉林大学学报:医学版,2015,41(1):120-124.
    [14]QIN J,XU Y,LI X,et al.Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell[J].Exp Mol Pathol,2014,96(1):1-8.
    • Relative Articles

  • Relative Articles

    [1]Yunchong WU, Yanyan YANG, Chuan LI, Xiaohuan WU, Shide LIN. Role of inflammatory cytokines in disorder of glucose metabolism in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1886-1890. doi: 10.12449/JCH240926
    [2]Jianan ZHAO, Jinghua PENG, Ping LIU, Yiyang HU. Effect of Cordyceps polysaccharides on hepatocyte apoptosis induced by tumor necrosis factor-α[J]. Journal of Clinical Hepatology, 2021, 37(6): 1368-1372. doi: 10.3969/j.issn.1001-5256.2021.06.029
    [3]Zhen TIAN, Lisha WANG, Naijuan YAO, Yingren ZHAO, Litao RUAN. Role and mechanism of hepatic stellate cells in the pathogenesis of mice with acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2021, 37(3): 642-647. doi: 10.3969/j.issn.1001-5256.2021.03.027
    [4]Lihui ZHANG, Minghao LIU, Wenxia ZHAO. Role of lipotoxicity in the development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(2): 463-466. doi: 10.3969/j.issn.1001-5256.2021.02.045
    [5]Qu Yao, Zhang Wei. Role of cell apoptosis in the pathogenesis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1397-1400. doi: 10.3969/j.issn.1001-5256.2019.06.049
    [6]Gong Jing, Jie XinKe. Effect of endoplasmic reticulum stress and autophagy on hepatocyte apoptosis[J]. Journal of Clinical Hepatology, 2019, 35(12): 2828-2832. doi: 10.3969/j.issn.1001-5256.2019.12.041
    [7]Gao Si, Zhao XiangXuan, Lu ZaiMing. Role of cell apoptosis regulated by P53 in treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(7): 1373-1376. doi: 10.3969/j.issn.1001-5256.2017.07.038
    [8]Zhang ChaoYa, Zhao XiangXuan, Lu ZaiMing, Guo QiYong. Research advances in sorafenib- induced apoptotic signaling pathways in liver cancer cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 816-820. doi: 10.3969/j.issn.1001-5256.2016.04.048
    [9]Pan LiuLan, Jia ShengNan, Ma JingTing, Tai JingHua, Jin ZhenJing. Effect of decoy receptor 3 gene on hepatocyte apoptosis[J]. Journal of Clinical Hepatology, 2016, 32(7): 1330-1333. doi: 10.3969/j.issn.1001-5256.2016.07.023
    [10]Wang YingChun, Kong WeiZong, Jin QingMei, Chen Juan. Effect of salvianolic acid B on hepatocyte apoptosis in rats with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1325-1329. doi: 10.3969/j.issn.1001-5256.2014.12.022
    [11]Pan YuanWei, Ping Jian, Xu LieMing. Research advances in main signaling pathways for inducing apoptosis of activated hepatic stellate cells[J]. Journal of Clinical Hepatology, 2014, 30(2): 182-185. doi: 10.3969/j.issn.1001-5256.2014.02.021
    [12]Wang XiXun, Jiang LiXin, Wang JingLin, Liang Jing, Zhai HuiYuan, Xia XianMing. Experimental study on hepatocyte apoptosis induced by acute biliary tract infection[J]. Journal of Clinical Hepatology, 2014, 30(11): 1164-1168. doi: 10.3969/j.issn.1001-5256.2014.11.018
    [13]Weng ShanGeng, Xu ChangGuo, Sun Ying, Shi Zheng, Lin LiJuan. Study on the apoptosis of rat hepatic stellate cells induced by kapamycin[J]. Journal of Clinical Hepatology, 2012, 28(3): 219-222.
    [14]Qiao ChunPing, Chen YueXiang. Advances in study of the relationship between apoptosis and alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 386-390.
    [15]Cheng Rui, Cai XinRan, Zhou HaoHui, Han ShengHua, Zhu JinHai, Chen HuiXing, Chen YanLing. Omega-3 polyunsaturated fatty acids inhibit inflammation during the early stage of acute pancreatitis[J]. Journal of Clinical Hepatology, 2012, 28(8): 598-602.
    [16]Zhang LiLi, Guo XiaoHong, Liu LiXin, Zhang QianQian. IGFBPrP1 siRNA induced apoptosis in rat hepatic stellate cells and its mechanism[J]. Journal of Clinical Hepatology, 2011, 27(9): 965-969+979.
    [17]Zhang Biao, Sui Tao, Yu XiuYing, Cao YongXian, Yao Yuan, He Hong. Significance of detecting apoptosis of PBMC and cytokine of supernatant induced by PHA in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(3): 138-140.
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(2)

    1. 马宏涛，李璐辰，刘汝杰，李润东，王磊. 水飞蓟宾联合阿昔莫司口服治疗非酒精性脂肪性肝炎的疗效及安全性观察. 山东医药. 2024(14): 49-52 .
    2. 肖炜，王欣鑫，张坪，周斌，唐奇志，李世香. 从病因病机共性探讨2型糖尿病、非酒精性脂肪性肝病与高尿酸血症内在联系. 中国中医药图书情报杂志. 2024(06): 13-17 .

    Other cited types(2)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 53.5 %FULLTEXT: 53.5 %META: 40.6 %META: 40.6 %PDF: 5.9 %PDF: 5.9 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 8.5 %其他: 8.5 %其他: 1.0 %其他: 1.0 %Kao-sung: 0.2 %Kao-sung: 0.2 %Toyoake: 0.1 %Toyoake: 0.1 %[]: 0.1 %[]: 0.1 %上海: 5.6 %上海: 5.6 %丽水: 0.1 %丽水: 0.1 %佛山: 0.5 %佛山: 0.5 %保定: 0.1 %保定: 0.1 %兰州: 0.2 %兰州: 0.2 %北京: 4.9 %北京: 4.9 %南京: 0.5 %南京: 0.5 %南充: 0.1 %南充: 0.1 %南宁: 0.3 %南宁: 0.3 %南昌: 0.2 %南昌: 0.2 %卡纳塔克: 0.2 %卡纳塔克: 0.2 %厦门: 0.4 %厦门: 0.4 %台北: 0.1 %台北: 0.1 %台州: 0.9 %台州: 0.9 %吉林: 0.4 %吉林: 0.4 %呼和浩特: 0.1 %呼和浩特: 0.1 %哈尔滨: 0.2 %哈尔滨: 0.2 %嘉兴: 0.2 %嘉兴: 0.2 %天津: 0.2 %天津: 0.2 %太原: 0.5 %太原: 0.5 %威海: 0.1 %威海: 0.1 %孝感: 0.2 %孝感: 0.2 %孟买: 0.2 %孟买: 0.2 %宣城: 0.1 %宣城: 0.1 %常州: 0.2 %常州: 0.2 %常德: 0.1 %常德: 0.1 %广州: 1.5 %广州: 1.5 %弗吉: 0.1 %弗吉: 0.1 %张家口: 2.1 %张家口: 2.1 %徐州: 0.1 %徐州: 0.1 %成都: 0.9 %成都: 0.9 %新德里: 0.1 %新德里: 0.1 %无锡: 0.1 %无锡: 0.1 %昆明: 0.3 %昆明: 0.3 %晋中: 0.1 %晋中: 0.1 %朝阳: 0.1 %朝阳: 0.1 %杭州: 1.4 %杭州: 1.4 %武汉: 1.5 %武汉: 1.5 %水原: 0.1 %水原: 0.1 %沈阳: 0.3 %沈阳: 0.3 %沧州: 0.1 %沧州: 0.1 %法尔肯施泰因: 1.8 %法尔肯施泰因: 1.8 %泰州: 0.3 %泰州: 0.3 %泸州: 0.1 %泸州: 0.1 %洛杉矶: 0.1 %洛杉矶: 0.1 %洛阳: 0.5 %洛阳: 0.5 %济南: 0.2 %济南: 0.2 %济宁: 0.2 %济宁: 0.2 %海口: 0.4 %海口: 0.4 %海得拉巴: 0.4 %海得拉巴: 0.4 %淄博: 0.2 %淄博: 0.2 %深圳: 0.1 %深圳: 0.1 %湖州: 0.4 %湖州: 0.4 %湘潭: 0.1 %湘潭: 0.1 %湛江: 0.1 %湛江: 0.1 %漯河: 0.2 %漯河: 0.2 %牡丹江: 0.2 %牡丹江: 0.2 %石家庄: 0.2 %石家庄: 0.2 %福州: 0.2 %福州: 0.2 %红河: 0.1 %红河: 0.1 %纽约: 0.1 %纽约: 0.1 %罗奥尔凯埃: 0.1 %罗奥尔凯埃: 0.1 %芒廷维尤: 39.1 %芒廷维尤: 39.1 %芝加哥: 0.7 %芝加哥: 0.7 %苏州: 0.3 %苏州: 0.3 %苏拉卡尔塔: 0.2 %苏拉卡尔塔: 0.2 %莫斯科: 0.1 %莫斯科: 0.1 %衡水: 0.2 %衡水: 0.2 %衡阳: 0.1 %衡阳: 0.1 %衢州: 1.0 %衢州: 1.0 %襄阳: 0.1 %襄阳: 0.1 %西宁: 8.2 %西宁: 8.2 %西安: 1.3 %西安: 1.3 %诺沃克: 0.3 %诺沃克: 0.3 %贵阳: 0.3 %贵阳: 0.3 %赣州: 0.3 %赣州: 0.3 %赤峰: 0.1 %赤峰: 0.1 %运城: 1.0 %运城: 1.0 %连云港: 0.1 %连云港: 0.1 %通辽: 0.1 %通辽: 0.1 %邯郸: 0.4 %邯郸: 0.4 %郑州: 0.6 %郑州: 0.6 %重庆: 0.6 %重庆: 0.6 %铜仁: 0.1 %铜仁: 0.1 %锦州: 0.1 %锦州: 0.1 %长春: 1.0 %长春: 1.0 %长沙: 1.4 %长沙: 1.4 %长治: 0.1 %长治: 0.1 %阿什本: 0.8 %阿什本: 0.8 %阿坝: 0.1 %阿坝: 0.1 %青岛: 0.3 %青岛: 0.3 %鞍山: 0.1 %鞍山: 0.1 %鸡西: 0.1 %鸡西: 0.1 %黄石: 0.2 %黄石: 0.2 %其他其他Kao-sungToyoake[]上海丽水佛山保定兰州北京南京南充南宁南昌卡纳塔克厦门台北台州吉林呼和浩特哈尔滨嘉兴天津太原威海孝感孟买宣城常州常德广州弗吉张家口徐州成都新德里无锡昆明晋中朝阳杭州武汉水原沈阳沧州法尔肯施泰因泰州泸州洛杉矶洛阳济南济宁海口海得拉巴淄博深圳湖州湘潭湛江漯河牡丹江石家庄福州红河纽约罗奥尔凯埃芒廷维尤芝加哥苏州苏拉卡尔塔莫斯科衡水衡阳衢州襄阳西宁西安诺沃克贵阳赣州赤峰运城连云港通辽邯郸郑州重庆铜仁锦州长春长沙长治阿什本阿坝青岛鞍山鸡西黄石

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2126) PDF downloads(409) Cited by(4)
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2490]YesterdayPV[5108]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return